Skip to search.
 FTSE 100 Down 1.27%

Rockwell Medical, Inc. (RMTI)

-NasdaqGM
9.22 Down 0.54(5.53%) 16:56 - Nasdaq Real Time Price
Prev Close:9.76
Open:9.65
Bid:9.10 x 1100
Ask:9.12 x 700
1y Target Est:9.80
Beta:2.59396
Earnings Date:5 May - 9 May (Est.)
Day's Range:9.02 - 9.89
52wk Range:5.47 - 18.90
Volume:222,285
Avg Vol (3m):603,997
Market Cap:475.07m
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for RMTI at this time.

Comparison

Symbol% ChgMkt Cap
RMTIDown 5.53%475.07m

Key Statistics

Forward P/E (1 yr):27.58
P/S (ttm):8.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.11
Quarterly EPS Est (Mar-16) :-0.08
Mean Recommendation*:3.6
PEG Ratio (5 yr expected):-1.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease, iron deficiency, secondary h... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback